Risk of acute kidney injury associated with the use of fluoroquinolones.
about
Tamsulosin treatment for benign prostatic hyperplasia and risk of severe hypotension in men aged 40-85 years in the United States: risk window analyses using between and within patient methodologyThe growth of acute kidney injury: a rising tide or just closer attention to detail?Nonantibiotic Effects of Fluoroquinolones in Mammalian Cells.Drug-induced impairment of renal function.Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.Acute kidney injury-epidemiology, outcomes and economics.Safety issues and drug-drug interactions with commonly used quinolones.Antibiotic prophylaxis in cirrhosis: Good and bad.Antibiothérapie du sujet âgé : On peut toujours mieux faire.Drug Class Combination-Associated Acute Kidney Injury.Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.Dr Ben Franklin and an unusual modern-day cure for recurrent pleuritis.Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies?Trimethoprim use for urinary tract infection and risk of adverse outcomes in older patients: cohort study.Beneficial effects of quercetin on renal injury and oxidative stress caused by ciprofloxacin in rats: A histological and biochemical study.Off-label use of oral fluoroquinolone antibiotics in outpatient settings in the United States, 2006 to 2012.Communication and ciprofloxacin-associated acute kidney injury
P2860
Q28301391-EC1B8BA3-DDBC-4A38-9518-FC95B4AB86A0Q34439098-42863E6F-6422-4713-A311-662BEF2DA3F4Q34486609-DA3FD580-9C78-48A2-A5FC-8E156D66C489Q34731462-343781DF-7AA8-4DC1-8F8F-472BCC5603EAQ37724289-58B92755-F6E2-4497-A200-FAE3CA70FEB8Q38180360-4E126440-AFC3-4ABB-9642-670455B68D53Q38271318-DC2EA42C-65F5-4521-A3AD-71A986321BE3Q38623328-47509BD7-8BFB-4162-8D49-D566DE23052CQ38862567-AA7295B4-11BE-4EE7-9439-6E39707C661EQ38889504-402E5679-8813-40EB-8D23-B41AC67909C8Q42591462-E0FC4877-66BB-4E5C-991E-1B9450AEC933Q45049860-EE6F3309-D663-416A-9C99-D19267ACCE1AQ48156007-18EE3A93-94B2-4760-BC05-D27E4FBAA38DQ49848575-D5DC1D0F-AB3F-44C8-A8FE-8F8762A1C374Q51028638-5E8EA846-1415-4107-B86E-8C7D6F05E579Q53815076-C91E50C9-5C57-44A0-BF68-F9C572EE990CQ58805898-F03ECC72-CB69-4F79-A12A-D42B820BECA4
P2860
Risk of acute kidney injury associated with the use of fluoroquinolones.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk of acute kidney injury associated with the use of fluoroquinolones.
@en
Risk of acute kidney injury associated with the use of fluoroquinolones.
@nl
type
label
Risk of acute kidney injury associated with the use of fluoroquinolones.
@en
Risk of acute kidney injury associated with the use of fluoroquinolones.
@nl
prefLabel
Risk of acute kidney injury associated with the use of fluoroquinolones.
@en
Risk of acute kidney injury associated with the use of fluoroquinolones.
@nl
P2093
P2860
P356
P1476
Risk of acute kidney injury associated with the use of fluoroquinolones.
@en
P2093
Abraham G Hartzema
Mahyar Etminan
Steven T Bird
P2860
P304
P356
10.1503/CMAJ.121730
P407
P577
2013-06-03T00:00:00Z